Greater China

The Covid-19 coronavirus has thrown up many challenges for bankers forced to work from home. But perhaps none is tougher than trying their very best to pretend they’re getting anything done.

Thomas Hugger has more than two decades of investment experience in frontier markets. Volatility is part of the job description. But he has never faced challenges like those unleashed by the Covid-19 pandemic.

Huangshan Tourism Group Co opted for euros for its maiden offshore bond. The €230m transaction benefited from a standby letter of credit from Bank of China’s Anhui branch, as well as strong bookrunner support.

Road King Infrastructure found strong support for its high yield dollar deal on Tuesday, gathering $2bn of orders for a $300m transaction.

Nongfu Sping, a Chinese bottled water and beverage company, is closing the international book for its Hong Kong IPO a day earlier than planned on the back of strong demand, according to sources close to the deal.

Hainan Airlines Holding Co, the flagship carrier of embattled Chinese conglomerate HNA Group, has convinced investors to wait for nine more months for their principal investment in a domestic bond.

Chinese internet and data centre services provider 21Vianet Group has raised $352.8m from a primary issue of its Nasdaq-listed stock.

Shandong Commercial Group Co followed its Chinese state-owned peers into the dollar market on Tuesday, but found limited support from investors for its $180m unrated bond.

Genting Hong Kong, a cruise ship operator under financial pressure due to the pandemic, held a meeting on Monday with its bank creditors to discuss a debt restructuring plan.

Compart Systems, a high precision metal components maker, has returned to the loan market to refinance an old borrowing from 2016, which was used to support its buyout by Platinum Private Equity.

Ant Group has taken a step closer to pulling off what is expected to be the world’s largest ever share offering, submitting IPO applications in Hong Kong and Shanghai on Tuesday.

Yidu Tech, a Chinese technology-based healthcare provider, is seeking approval for a Hong Kong IPO.